http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100492017-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2510-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-861 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10 |
| filingDate | 2002-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2005-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2005-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100492017-B1 |
| titleOfInvention | Method for anticancer treatment using human mesenhymal stem cell |
| abstract | The present invention relates to the use of adenovirus vectors for genetically modifying human mesenchymal stem cells to secrete excessive amounts of p53, a cancer suppressor protein, and use them for anticancer therapy. Specifically, the present invention relates to the use of adenovirus-induced mesenchymal stem cells to secrete an excess of p53, a tumor suppressor gene, and to use the same for anticancer therapy. The method for producing stem cells may be usefully used for the treatment of tumors. |
| priorityDate | 2002-06-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.